首页 / 词典 / good

抗栓酶

  • 网络Ahylysantinfarctase;Svate
抗栓酶抗栓酶
  1. 目的探讨蝮蛇抗栓酶治疗突发性耳聋的效果。

    Objective To discuss the effect of SVATE on sudden deafness .

  2. 方法将7年的蝮蛇抗栓酶治疗组28例30耳,与扩管药物治疗组28例30耳,进行回顾性对比分析。

    Methods The retrospective study of28 cases ( 30 ears ) treated with SVATE was conducted and compared , with28cases ( 30 ears ) treated with other drug .

  3. PCNA和bcl-2在翼状胬肉成纤维细胞中的表达及蝮蛇抗栓酶的影响

    Expression of PCNA and bcl-2 on cultured human pterygium fibroblasts and the effects of Ahylysantinfarctase

  4. 提示蝮蛇抗栓酶具有体内抗氧化作用,提高体内SOD水平,促进体内抗脂质过氧化的作用。

    It suggested that this enzyme plays a role in antioxidation , increases the level of SOD in vivo and promotes the anti-lipid hyperoxidation .

  5. 应用蝮蛇抗栓酶治疗流行性出血热(EHF)40例。

    Ahylysantinfarctase was used to treat 40 cases of epidemic hemorrhagic fever ( EHF ) .

  6. 蝮蛇抗栓酶对实验性动脉粥样硬化与PGI2/TXA2平衡影响的观察

    Observation on pgi2 / txa2 balancing with Svate used to the experimental atherosclerosis

  7. 目的研究蝮蛇抗栓酶(AF)对胎儿晶状体上皮细胞体外生长的影响。

    Objective To study the effect of ahylysantinfarctase ( AF ) on the growth of fetus lens epithelial cells ( LECs ) in vitro .

  8. 提示蛇毒抗栓酶可能通过提高tPA及6-K-PGF1α含量纠正高凝状态和纤溶功能低下,使基础治疗更能发挥作用。

    It was showed that Svate-3 could correct hypercoagulability and improve fibrinolysis function by raising the contents of tPA and 6-k-PGF1 α, so it could improve the basal treatment .

  9. 目的研究精制腹蛇抗栓酶(SVATE-3)在溶栓治疗中对冠脉血栓再通及再闭塞的干预。

    Objective To study the effects of snake venom antithrombotic enzyme ( SVATE-3 ) on re-occlusion after thrombolysis to acute coronary thrombosis .

  10. 为临床治疗急性呼吸窘迫综合征(ARDS)寻找新的有效药物,选用蝮蛇抗栓酶(Svate)对ARDS动物模型进行防治,观察疗效。

    To find new drugs which have good therapeutic effect on acute lung injury ( even to acute respiratory distress syndrome , ARDS ), svate was selected to treat the ARDS in rat models .

  11. 实验分为单纯缺血再灌注组(I-R组)和蝮蛇抗栓酶治疗组(A.H组,灌流液中加入A.H2.5u/L)。

    The study was divided into two groups : ischemia - reperfusion group ( I - R group ) and A.

  12. 用蛇毒抗栓酶以自身对照方法治疗17例急性心肌梗塞、38例心绞痛和19例高血压病患者,分别测定不同治疗时间患者血浆TXB2、6酮PGF1α浓度。

    A self-controlled study was done in 17 cases with AMI , 38 cases with angina , 19 cases with hypertension . The levels of plasma TXB_2 and 6-keto-PGF_1 α were measured in various day of trea (?)

  13. 本实验以异丙肾上腺素性心肌缺血(ISP-MI)为模型,对心肌膜脂、膜酶及自由基系统三个方面进行了研究,旨在探讨蝮蛇抗栓酶(Svate)对膜损伤的修饰作用。

    Changes in lipids , enzymes and free-radical system of myocardial membranes were investigated in isoproterenol-induced myocardial infarction so as to study the modulative effects of Svate on myocardial membrane injury .

  14. 本文观察了大鼠心肌缺血再灌注后血小板5-HT2A受体、血浆5-HT,心肌CPK的变化,及蛇毒抗栓酶对其影响。

    The changes of platelet 5-HT 2A receptor , plasma 5-HT level and myocardial CPK activity and the effect of snake venom anti-thrombus enzyme ( SVATE ) were observed in the rat subjected to left coronary artery occlusion for one hour followed by one hour reperfusion .

  15. 方法:40例DN患者入院后给予治疗糖尿病饮食,用胰岛素控制血糖、尿糖在正常范围,并把40例DN患者随机分成脉络宁治疗组和蝮蛇抗栓酶治疗组。

    Methods : Forty cases of DN were treated with diabetic diet , and to control the blood sugar and urine sugar in normal range with insulin . In addition , Forty cases were divided randomly into two groups : mai luo ning injection treatment group and ahylysantinfarctase treatment group .

  16. 本实验采用Langendorff离体心脏灌流模型,观察了大鼠心肌缺血(15cmH2O,20min)再灌注(70cmH2O,30min)后心肌的机能、代谢改变及蝮蛇抗栓酶对其影响。

    The functional and metabolic changes in isolated working rat heart following myocardial ischemia ( 15cm H_2O , 20min ) and reperfusion ( 70cm H_2O , 30min ), and the effect of A. Halys on the above changes were observed in the Langendorff Heart Model .

  17. 治疗组在对照组常规抗炎、利尿、强心、平喘等治疗基础上,加用蝮蛇抗栓酶0.5u加在5%葡萄糖300ml液中,静脉点滴,每日1次,7日为一疗程。

    The control group received normal western drugs including anti-infective , diuretic , cardiac tonic and antiasthmatic , and the treatment group was given western drugs plus intravenous ahylysantinfarctase 0 . 5u ( dissolved in 5 % glucose 300ml ) once daily for 7 days .

  18. 蝮蛇抗栓酶在结核性胸腔积液治疗中的抗纤维化作用

    The Role of Ahylysantinfarctase in Reducing Fibrosis of Tuberculous Pleural Effusion

  19. 蝮蛇抗栓酶改善肺心病高凝状态临床观察

    Clinical Observation on Ahylysantinfarctase for Improving Hypercoagulability of Pulmonary Heart Disease

  20. 蝮蛇抗栓酶治疗重度冻伤的临床研究

    The clinical investigation on treatment of severe frostbite with ahylysantinfarctase

  21. 抗栓酶3号对家兔血浆组织型纤溶酶原激活剂及其抑制物的影响

    The Effects of Svate-3 on tPA and PAI of Rabbits

  22. 乙二胺四醋酸二钠对蝮蛇抗栓酶毒性的影响

    Influence of EDTA_2 Na on Toxicity of Antithrombotic Esterase from Pit Viper

  23. 抗栓酶-3号对实验性兔矽肺治疗作用的观察

    Effect of Svate-3 on the treating experimental silicotic rabbits

  24. 蝮蛇抗栓酶引起出血的分析与护理

    Prevention and Nursing Care of Hemorrhage Induced by Ahylysantinfarctase

  25. 蝮蛇抗栓酶过敏性试验方法研究

    Studies on the experimental method for allergy of AHALYSANTINFARCTASUM

  26. 蝮蛇抗栓酶对冻伤家兔血凝系统某些指标的影响

    Effects of ahylysantinfarctase on some parameters of blood coagulation system in frostbitten rabbits

  27. 蝮蛇抗栓酶的临床副作用

    Clinical side effect of Agkistrodon halys antithrombotic enzyme

  28. 蝮蛇抗栓酶对实验性急性心肌梗塞的影响

    Effect of Agkistrodon Halys on Experimental Myocardial Infarction

  29. 设置正常对照组、糖尿病对照组及糖尿病治疗组。各治疗组分别采用川芎嗪、山莨菪碱、蝮蛇抗栓酶及卡托普利进行治疗,每周5次,共14周。

    Set normal control group , diabetes control group , and diabetes treatment group .

  30. 蝮蛇抗栓酶对胎儿晶状体上皮细胞体外生长的影响

    The effect of ahylysantinfarctase on the growth of fetus lens epithelial cells in vitro